Literature DB >> 33495102

Structural and chemical heterogeneities of primary hyperoxaluria kidney stones from pediatric patients.

Yuan Du1, Vincent Blay Roger2, Jorge Mena3, Misun Kang2, Marshall L Stoller3, Sunita P Ho4.   

Abstract

OBJECTIVE: Calcium oxalate stones are the most common type among stone-forming patients and in some cases result from predisposed genetic conditions. In this work, we examined the differences in structure and chemical composition between oxalate stones from patients from three groups: 1) pediatric patients that were genetically predisposed (primary hyperoxaluria) to form stones (PPH); 2) control pediatric patients that did not have such genetic predisposition (PN-PH); 3) adult patients that formed oxalate stones without the genetic predisposition (A-CaOx). A variety of instrumental analyses were conducted to identify physicochemical properties of stones characteristic of predisposed pediatric (PPH), pediatric hyperoxaluria (PN-PH), and adult (A-CaOx) patient populations.
METHODS: Genetic variants of 16 stone-forming patients were determined using whole-exome gene sequencing. Components of stones from PPH (n = 6), PN-PH (n = 5), and A-CaOx (n = 5) groups were identified using Fourier transform infrared (FTIR) spectroscopy. Stone morphology and density were evaluated using high resolution X-ray computed tomography (micro-XCT). Stone microstructure and elemental composition were mapped with scanning electron microscopy (SEM) and energy dispersive X-ray (EDX) spectroscopy, respectively.
RESULTS: Calcium oxalate bipyramidal crystals were found on stones from all groups. Stones from PPH patients with PH types I and II were composed of calcium oxalate monohydrate (COM) with relatively uniform mineral density (1224 ± 277 mg/cc) and distinct smooth surfaces. By contrast, micro-spherical calcium phosphate particles were found only on PN-PH stones, which also showed a broader range of mineral densities (1266 ± 342 mg/cc). Stones from the PN-PH group also contained phosphorus (P), which was absent in NP-PH stones. A-CaOx stones were of significantly lower mineral density (645 ± 237 mg/cc) than pediatric stones and were more heterogeneous in their elemental composition.
CONCLUSION: Unique structural and compositional characteristics were identified in stones from pediatric patients with primary hyperoxaluria. These include the absence of phosphorus, a narrower mineral density distribution, and a uniform elemental composition compared to stones from pediatric patients without the genetic predisposition. Thus, characterization of stones at the macro- and micro-scales in combination with genetic testing of patients can provide insights and accurate diagnosis to develop a treatment plan for effective patient care.
Copyright © 2020 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hyperoxaluria; Kidney stones; Microscopy; Spectroscopy; Whole-exome sequencing; XCT

Mesh:

Substances:

Year:  2020        PMID: 33495102      PMCID: PMC8709938          DOI: 10.1016/j.jpurol.2020.11.023

Source DB:  PubMed          Journal:  J Pediatr Urol        ISSN: 1477-5131            Impact factor:   1.830


  34 in total

1.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

Review 2.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

Review 3.  Primary hyperoxaluria.

Authors:  Pierre Cochat; Gill Rumsby
Journal:  N Engl J Med       Date:  2013-08-15       Impact factor: 91.245

4.  Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study.

Authors:  Vidar O Edvardsson; Solborg E Ingvarsdottir; Runolfur Palsson; Olafur S Indridason
Journal:  Pediatr Nephrol       Date:  2018-04-06       Impact factor: 3.714

5.  Peculiar morphology of stones in primary hyperoxaluria.

Authors:  Michel Daudon; Paul Jungers; Dominique Bazin
Journal:  N Engl J Med       Date:  2008-07-03       Impact factor: 91.245

6.  Surgical management of stone disease in patients with primary hyperoxaluria.

Authors:  Alonso Carrasco; Candace F Granberg; Matthew T Gettman; Dawn S Milliner; Amy E Krambeck
Journal:  Urology       Date:  2015-03       Impact factor: 2.649

7.  Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies.

Authors:  Maria Goretti Moreira Guimarães Penido; Marcelo de Sousa Tavares
Journal:  World J Nephrol       Date:  2015-09-06

8.  Kidney stone analysis: "Give me your stone, I will tell you who you are!".

Authors:  Jonathan Cloutier; Luca Villa; Olivier Traxer; Michel Daudon
Journal:  World J Urol       Date:  2014-12-03       Impact factor: 4.226

9.  Unambiguous observation of shape effects on cellular fate of nanoparticles.

Authors:  Zhiqin Chu; Silu Zhang; Bokai Zhang; Chunyuan Zhang; Chia-Yi Fang; Ivan Rehor; Petr Cigler; Huan-Cheng Chang; Ge Lin; Renbao Liu; Quan Li
Journal:  Sci Rep       Date:  2014-03-28       Impact factor: 4.379

10.  Shape-dependent cellular toxicity on renal epithelial cells and stone risk of calcium oxalate dihydrate crystals.

Authors:  Xin-Yuan Sun; Jian-Ming Ouyang; Kai Yu
Journal:  Sci Rep       Date:  2017-08-03       Impact factor: 4.379

View more
  2 in total

Review 1.  Primary hyperoxaluria: the adult nephrologist's point of view.

Authors:  Shabbir H Moochhala; Elaine M Worcester
Journal:  Clin Kidney J       Date:  2022-05-17

2.  Integrative Functional Genomic Analysis in Multiplex Autism Families from Kazakhstan.

Authors:  Anastassiya Perfilyeva; Kira Bespalova; Yuliya Perfilyeva; Liliya Skvortsova; Lyazzat Musralina; Gulnur Zhunussova; Elmira Khussainova; Ulzhan Iskakova; Bakhytzhan Bekmanov; Leyla Djansugurova
Journal:  Dis Markers       Date:  2022-09-26       Impact factor: 3.464

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.